Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Clinical trials leading to FDA approval demonstrated significant visceral fat reduction in patients with excess abdominal fat accumulation, validating what clinicians now see consistently in practice
Brand-name Zepbound lists at about $1,059 per month, with LillyDirect at $349 to $499 per month for vials
Tirzepatide: Dual GIP/GLP-1 Receptor Agonism Tirzepatide (LY3298176) is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), with a C20 fatty diacid moiety for albumin binding
Polycystic ovaries Lastly, an ultrasound scan is done to check for an enlarged ovary and/or the presence of multiple cysts in the ovaries
US$ 27.53
US$ 29.87
US$ 20.27
US$ 21.53
